The clinical impact of switching attention deficit hyperactivity disorder patients from OROS(®)-MPH to Novo-MPH ER-C(®): A paediatric practice review

Lignende værker

• Emotional dysregulation in children with attention-deficit/hyperactivity disorder
  af: van Stralen, Judy
  Udgivet: (2016)
• Combination and Switching of Stimulants in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec
  af: Ben Amor, Leila, et al.
  Udgivet: (2014)
• Attention-deficit disorder (attention-deficit/hyperactivity disorder without hyperactivity): A neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)
  af: DIAMOND, ADELE
  Udgivet: (2005)
• Canadian Paediatric Society clinical practice recommendations for children and adolescents with attention-deficit hyperactivity disorder
  af: Bélanger, Stacey A
  Udgivet: (2018)
• The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
  af: Rausch, Tessa L., et al.
  Udgivet: (2017)